Company Filing History:
Years Active: 2021
Title: Joerg Hoernschemeyer: Innovator in Pharmaceutical Formulations
Introduction
Joerg Hoernschemeyer is a notable inventor based in Loerrach, Germany. He has made significant contributions to the field of pharmaceutical formulations, particularly through his innovative work on peptidomimetic macrocycles. His research focuses on developing aqueous pharmaceutical formulations that have the potential to treat various diseases and disorders.
Latest Patents
Hoernschemeyer holds 1 patent for his invention titled "Peptidomimetic macrocycles and formulations thereof." This patent discloses aqueous pharmaceutical formulations for parenteral administration that comprise peptidomimetic macrocycles or pharmaceutically acceptable salts. These macrocycles are designed to bind to MDM2 and/or MDMX proteins, which are crucial in the treatment of certain diseases.
Career Highlights
Joerg Hoernschemeyer is currently associated with Aileron Therapeutics, Inc., where he continues to advance his research in pharmaceutical sciences. His work is characterized by a commitment to innovation and the development of effective therapeutic solutions.
Collaborations
Some of his notable coworkers include David Allen Annis and Krzysztof Darlak, who contribute to the collaborative efforts in research and development at Aileron Therapeutics.
Conclusion
Joerg Hoernschemeyer's contributions to the field of pharmaceutical formulations exemplify the impact of innovative research on healthcare. His work on peptidomimetic macrocycles holds promise for advancing treatment options for various diseases.